FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30093711000001102: Rizatriptan 10mg tablets (DE Pharmaceuticals) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93740101000001114 Rizatriptan 10mg tablets (DE Pharmaceuticals) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93740201000001119 Rizatriptan 10mg tablets (DE Pharmaceuticals) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rizatriptan 10mg tablets (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (DE Pharmaceuticals) Is a Product containing precisely rizatriptan (as rizatriptan benzoate) 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (DE Pharmaceuticals) Has active ingredient Rizatriptan benzoate false Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (DE Pharmaceuticals) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (DE Pharmaceuticals) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (DE Pharmaceuticals) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (DE Pharmaceuticals) Has specific active ingredient Rizatriptan benzoate true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (DE Pharmaceuticals) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (DE Pharmaceuticals) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (DE Pharmaceuticals) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (DE Pharmaceuticals) Has basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Rizatriptan 10mg tablets (DE Pharmaceuticals) 3 tablet Has AMP True Rizatriptan 10mg tablets (DE Pharmaceuticals) Inferred relationship Existential restriction modifier
Rizatriptan 10mg tablets (DE Pharmaceuticals) 6 tablet Has AMP True Rizatriptan 10mg tablets (DE Pharmaceuticals) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start